Since these models show severe obesity, hyperinsulinemia, and insulin resistance throughout their lives, the agents like insulin sensitizers, antiobesity, and some other antihyperglycemia agents, which decrease the body weight and improve peripheral insulin sensitivity, have been largely tested by making use of these obese rodent models [16, 17]. The gene discussed is INS; the disease is Hyperinsulinemia.